Literature DB >> 33534722

Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study.

Wanfa Dai1, Pei-Feng Ke2,3, Yujuan Xiong2,3, Xian-Zhang Huang2,3, Zhen-Zhen Li4, Qi-Zhen Zhuang4, Wei Huang1, Yi Wang2,4.   

Abstract

BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination.
OBJECTIVE: The objective of our study was to construct an effective model for the early identification of COVID-19 that would also distinguish it from CAP.
METHODS: The clinical laboratory indicators (CLIs) of 61 COVID-19 patients and 60 CAP patients were analyzed retrospectively. Random combinations of various CLIs (ie, CLI combinations) were utilized to establish COVID-19 versus CAP classifiers with machine learning algorithms, including random forest classifier (RFC), logistic regression classifier, and gradient boosting classifier (GBC). The performance of the classifiers was assessed by calculating the area under the receiver operating characteristic curve (AUROC) and recall rate in COVID-19 prediction using the test data set.
RESULTS: The classifiers that were constructed with three algorithms from 43 CLI combinations showed high performance (recall rate >0.9 and AUROC >0.85) in COVID-19 prediction for the test data set. Among the high-performance classifiers, several CLIs showed a high usage rate; these included procalcitonin (PCT), mean corpuscular hemoglobin concentration (MCHC), uric acid, albumin, albumin to globulin ratio (AGR), neutrophil count, red blood cell (RBC) count, monocyte count, basophil count, and white blood cell (WBC) count. They also had high feature importance except for basophil count. The feature combination (FC) of PCT, AGR, uric acid, WBC count, neutrophil count, basophil count, RBC count, and MCHC was the representative one among the nine FCs used to construct the classifiers with an AUROC equal to 1.0 when using the RFC or GBC algorithms. Replacing any CLI in these FCs would lead to a significant reduction in the performance of the classifiers that were built with them.
CONCLUSIONS: The classifiers constructed with only a few specific CLIs could efficiently distinguish COVID-19 from CAP, which could help clinicians perform early isolation and centralized management of COVID-19 patients. ©Wanfa Dai, Pei-Feng Ke, Zhen-Zhen Li, Qi-Zhen Zhuang, Wei Huang, Yi Wang, Yujuan Xiong, Xian-Zhang Huang. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 22.02.2021.

Entities:  

Keywords:  COVID-19; classification algorithm; classifier; clinical laboratory indicators; community-acquired pneumonia

Year:  2021        PMID: 33534722     DOI: 10.2196/23390

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  5 in total

Review 1.  Prognostic value of albumin-to-globulin ratio in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Juan R Ulloque-Badaracco; Melany D Mosquera-Rojas; Enrique A Hernandez-Bustamante; Esteban A Alarcón-Braga; Percy Herrera-Añazco; Vicente A Benites-Zapata
Journal:  Heliyon       Date:  2022-05-18

2.  Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection.

Authors:  F Gianfagna; G Veronesi; A Baj; D Dalla Gasperina; S Siclari; F Drago Ferrante; F Maggi; L Iacoviello; M M Ferrario
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

3.  Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning.

Authors:  Krishnaraj Chadaga; Chinmay Chakraborty; Srikanth Prabhu; Shashikiran Umakanth; Vivekananda Bhat; Niranjana Sampathila
Journal:  Interdiscip Sci       Date:  2022-02-08       Impact factor: 2.233

4.  Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia.

Authors:  Ane Uranga; Eloisa Urrechaga; Urko Aguirre; Maider Intxausti; Carlos Ruiz-Martinez; Maria Jose Lopez de Goicoechea; Cristina Ponga; Jose María Quintana; Cristina Sancho; Pilar Sanz; Pedro Pablo España
Journal:  Arch Bronconeumol       Date:  2022-09-21       Impact factor: 6.333

Review 5.  Clinlabomics: leveraging clinical laboratory data by data mining strategies.

Authors:  Xiaoxia Wen; Ping Leng; Jiasi Wang; Guishu Yang; Ruiling Zu; Xiaojiong Jia; Kaijiong Zhang; Birga Anteneh Mengesha; Jian Huang; Dongsheng Wang; Huaichao Luo
Journal:  BMC Bioinformatics       Date:  2022-09-24       Impact factor: 3.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.